Candriam SCA’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-269,000
| Closed | -$8.57M | – | 702 |
|
|
2024
Q1 | $8.57M | Buy |
269,000
+71,000
| +36% | +$2.26M | 0.05% | 273 |
|
|
2023
Q4 | $4.01M | Hold |
198,000
| – | – | 0.03% | 366 |
|
|
2023
Q3 | $2.52M | Buy |
198,000
+25,000
| +14% | +$318K | 0.02% | 416 |
|
|
2023
Q2 | $3.13M | Sell |
173,000
-62,000
| -26% | -$1.12M | 0.02% | 419 |
|
|
2023
Q1 | $3.72M | Buy |
+235,000
| New | +$3.72M | 0.03% | 428 |
|